glp-1 non-diabetic weight loss effectiveness medications are marketed to help you lose weight, but one may be better at it than the rest, according to a new meta-analysis from the UGA College of Pharmacy. Tirzepatide, better Long-term Success of GLP-1s Hinges

If we don't ask the patient, because if I was taking Ozempic and I was taking enough of it to make me vomit, I may have a stigma in my mind thinking, I don't want to say that because they're going to think, why would you do that

Morgan's February 2026 global research report projects a $3055 billion annual revenue reduction for the food and beverage industry by 20302034, attributable directly to GLP-1 adoption

They underscore not only the clinical impact of this drug class but also the urgent need to comprehensively review the evolving evidence base, clarify mechanistic insights, and explore future directions in both metabolic and non-metabolic disease contexts

As the most extensively studied GLP-1 receptor agonist in clinical history, semaglutide provides researchers with an unparalleled reference compound for GLP-1 pathway studies

Tramadol for Neuropathic Pain

Newly Expanded Accreditation Diabetes Education Services has teamed up with Partners for Advancing Clinical Education (Partners) to expand our accreditation offerings